RT Journal Article
SR Electronic
T1 Early stopping in clinical PET studies: ewline how to reduce expense and exposure
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.09.13.20192856
DO 10.1101/2020.09.13.20192856
A1 Svensson, Jonas
A1 Schain, Martin
A1 Knudsen, Gitte M.
A1 Ogden, Todd
A1 Plavén-Sigray, Pontus
YR 2021
UL http://medrxiv.org/content/early/2021/04/13/2020.09.13.20192856.abstract
AB Clinical positron emission tomography (PET) research is costly and entails exposing participants to radioactivity. Researchers should therefore aim to include just the number of subjects needed to fulfill the purpose of the study. In this tutorial we show how to apply sequential Bayes Factor testing in order to stop the recruitment of subjects in a clinical PET study as soon as enough data have been collected to make a conclusion. By using simulations, we demonstrate that it is possible to stop a study early, while keeping the number of erroneous conclusions low. We then apply sequential Bayes Factor testing to a real PET data set and show that it is possible to obtain support in favor of an effect while simultaneously reducing the sample size with 30%. Using this procedure allows researchers to reduce expense and radioactivity exposure for a range of effect sizes relevant for PET research.Competing Interest StatementThe authors have declared no competing interest.Funding StatementPPS was supported by the Swedish Society for Medical Research and the Lundbeck Foundation.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Study uses simulated or historical dataAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data code for reproducing the results, tables and figures in this article can be found at https://github.com/pontusps/Early_stopping_in_PET.